Ergomed PLC ORD 1P/ GB00BN7ZCY67 /

9/25/2023 3:24:26 PM	Chg. +6.3	Volume	Bid9/25/2023	Ask9/25/2023	High	Low
1,348.3GBX	+0.47%	215,955 Turnover(GBP): 2.91 mill.	1,348.0Bid Size: 20,311	1,350.0Ask Size: 31,864	1,352.0	1,348.0

GlobeNewswire 4/26/2021 Ergomed expands operations in Japan

GlobeNewswire 12/14/2020 Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO

GlobeNewswire 9/22/2020 Ergomed plc Interim results for the six months ended 30 June 2020

GlobeNewswire 7/21/2020 Ergomed H1 2020 Trading Update

GlobeNewswire 6/10/2020 Annual General Meeting Statement

GlobeNewswire 5/28/2020 Ergomed to Present at Jefferies Virtual 2020 Healthcare Conference

GlobeNewswire 5/18/2020 Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automati...

GlobeNewswire 4/6/2020 Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development ...

GlobeNewswire 3/30/2020 Ergomed’s PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial...

GlobeNewswire 3/25/2020 Audited Full Year Results for the year ended 31 December 2019

GlobeNewswire 3/18/2020 Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study

GlobeNewswire 1/29/2020 2019 Trading Update

GlobeNewswire 1/13/2020 Acquisition of Ashfield Pharmacovigilance Inc., a US pharmacovigilance services provider, from UDG H...